Manufacturing

EMA and MHRA provide insight into increased GMP deficiencies.

Careful attention to detail will help to prevent valuable assets from "melting" away.

A Q&A with Thomas E. D'Ambra, Chairman, CEO, & President of AMRI, on recent industry trends.

Taking time to appreciate the industry's greatest achievements will inspire growth ahead.

Readers point to quality by design as having a significant influence on manufacturing and drug development during the past decade.

Companies roll out expansions in manufacturing high-potency APIs and finished products.

Sponsor companies' increasing focus on strategic outsourcing has changed the rules of the game.

Developments in hot-melt extrusion using twin-screw extruders to make solid-dosage drug forms.

An industry roundtable on how users and makers can best assess and manage black specks.

Improvements in expression platforms and enhanced tools for selecting clones are among the advances of the past few decades.

Flow chemistry and microreactors offer alternatives to traditional batch manufacturing.

A look back at key nanoformulation advances and what lies ahead for nanoparticle-based drug-delivery systems.

Industry experts share perspectives on analytical instrumentation, methods, and data analysis.

Presidents of leading associations offer views on the industry's future.

Parallel trade has frustrated pharmaceutical manufacturers for years and now evidence has linked such trade to drug shortages in Europe. Parallel trade representatives have yet to respond, but will need to react quickly to salvage their reputation.

PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the June 2012 edition from EMD Millipore and Meissner Filtration Products.

Time- and cost-savings benefits help drive increased use of single-use, disposable systems in biopharmaceutical manufacturing.

An understanding of the pan-coating process based on first principles can support successful scale up.

Novartis, GlaxoSmithKline, and Lonza are among those participating in newly formed consortiums for developing and producing medical countermeasures.

European and US associations call for continued vigilance against the threat of counterfeit medicines.

In addition to the established coating systems (like the BFC and the BFC TriPan), Bohle developed a new coater to face the market needs, the Bohle-Tablet-Coater BTC.

Dr. Reddy's Laboratories and Merck Serono, a division of Merck KGaA, have partnered to codevelop a portfolio of biosimilar compounds in oncology.

The authors evaluate the thermal properties of gentamicin sulfate as a small-molecule drug model in optimizing the freeze-drying cycle.

Peptides and related technologies to are starting to improve production.

New product reviews for June 2012.

Extensive physicochemical characterization of the innovator product and the proposed biosimilar provides the foundation for demonstrating biosimilarity.

Industry wants more innovation, but can suppliers meet customer needs?

A Q&A with Larry Kadis, President and CEO of Federal Equipment, on recent industry trends.

Highlights included the latest in pharmaceutical packaging equipment, containers, and labels and new capabilities among contract service providers.

BIO is calling for a more patient-centric approach to user-fee reauthorization.